CN102670919A - Chinese medicament for treating chronic pyelonephritis - Google Patents

Chinese medicament for treating chronic pyelonephritis Download PDF

Info

Publication number
CN102670919A
CN102670919A CN2012101531352A CN201210153135A CN102670919A CN 102670919 A CN102670919 A CN 102670919A CN 2012101531352 A CN2012101531352 A CN 2012101531352A CN 201210153135 A CN201210153135 A CN 201210153135A CN 102670919 A CN102670919 A CN 102670919A
Authority
CN
China
Prior art keywords
grams
radix
chinese
chronic pyelonephritis
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101531352A
Other languages
Chinese (zh)
Inventor
宋协勘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012101531352A priority Critical patent/CN102670919A/en
Publication of CN102670919A publication Critical patent/CN102670919A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the field of Chinese medicaments, and in particular relates to a Chinese medicament for treating chronic pyelonephritis. The Chinese medicament is characterized by consisting of the following raw medicaments by weight: 40 to 45 grams of astragalus root, 20 to 25 grams of Chinese angelica, 30 to 35 grams of rehmannia root, 20 to 23 grams of fructus corni, 20 to 23 grams of Chinese yam, 10 to 12 grams of root-bark of tree peony, 10 to 12 grams of poria, 10 to 12 grams of rhizome of oriental water plantain, 10 to 12 grams of monkshood, 20 to 25 grams of kuh-seng, 60 to 65 grams of patrinia, 60 to 65 grams of dandelion, 30 to 35 grams of field thistle herb, 30 to 35 grams of cordate houttuynia, and 10 to 12 grams of licorice. The Chinese medicament for treating the chronic pyelonephritis has the advantages of good curative effect, short treatment course and high cure rate. The cure rate is 80 percent, and the improvement rate is 15 percent.

Description

A kind of Chinese medicine of treating chronic pyelonephritis
Technical field:
The present invention relates to a kind of Chinese medicine of treating chronic pyelonephritis.
Background technology:
Chronic pyelonephritis, clinical manifestation often are not true to type and are complicated and changeable, and great majority are by due to the acute pyelonephritis protracted course of disease.Clinical manifestation is similar with acute pyelonephritis, systemic infection symptom and kidney and urinary tract topical manifestations are arranged too, but symptom is lighter, to the later stage, the performance of renal tubular function infringement can be arranged.Also can develop into chronic renal insufficiency etc.Chronic pyelonephritis, undesirable with the general curative effect of antibiotic therapy, and also side effect is many.Up to now, doctor trained in Western medicine still lacks a kind of comparatively ideal Therapeutic Method.The pathogenic bacterium of traditional Chinese medical herbal treatment chronic pyelonephritis have suppress or kill and wound outside, and body's immunological function had good adjusting, the inflammatory damage of body is had repair.The traditional Chinese medical science belongs to chronic pyelonephritis within the category of diseases such as " lumbago, strangurias ".The theory of the traditional Chinese medical science " institute of heresy plays, and its gas must be empty " " pathogen usually intruding into collateral in protracted disease " " waist is a house of kidney " etc., according to these middle prescription QI invigorating invigorating kidney, promoting blood circulation, fever, detoxicating and treating chronic pyelonephritis curative effect height, the short treating period of my invention, have no toxic and side effects.
Summary of the invention:
The objective of the invention is in order to solve the deficiency of above-mentioned technology, a kind of good effect, short treating period, cure rate height are provided, can treat the Chinese medicine of chronic pyelonephritis effectively.For realizing above-mentioned purpose; A kind of Chinese medicine of treating chronic pyelonephritis is characterized in that it is made up of the component of following raw materials in weight drug ratio: Radix Astragali 40-45g, Radix Angelicae Sinensis 20-25g, Radix Rehmanniae 30-35g, Fructus Corni 20-23g, Rhizoma Dioscoreae 20-23g, Cortex Moutan 10-12g, Poria 10-12g, Rhizoma Alismatis 10-12g, Radix Aconiti Lateralis Preparata 10-12g, Radix Sophorae Flavescentis 20-25g, Herba Patriniae 60-65g, Herba Taraxaci 60-65g, Herba Cirsii 30-35g, Herba Houttuyniae 30-35g, Radix Glycyrrhizae 10-12g.
Chinese medicine of the present invention, the Radix Astragali: sweet, temperature is returned spleen, lung meridian, tonifying Qi and lifting yang, holder skin ulcer granulation promoting.Radix Angelicae Sinensis: sweet, suffering, hardship, temperature is returned liver, the heart, spleen channel, enriches blood, promoting blood circulation and stopping pain.The Radix Rehmanniae, sweet, hardship, cold, GUIXIN, liver, kidney channel, heat clearing away YIN nourishing, promoting the production of body fluid to quench thirst, cooling blood for hemostasis.Fructus Corni: acid, puckery, tepor, liver and kidney tonifying, arresting seminal emission reducing urination, consolidating channel for hemostasis.Rhizoma Dioscoreae: sweet, flat, return spleen, lung, kidney channel, lung, supplementing the kidney to control the nocturnal, YIN nourishing and the production of body fluid promoting are supported in spleen reinforcing.Cortex Moutan: hardship, suffering is slightly cold, GUIXIN, liver, kidney channel, clearing away heat and cooling blood, activating blood circulation and dissipating blood stasis.Poria: sweet, flat, GUIXIN, spleen, stomach, lung, kidney channel, promoting diuresis to eliminate damp pathogen, spleen invigorating invigorating middle warmer, mind tranquilizing and the heart calming.Rhizoma Alismatis: sweet, cold, return kidney, urinary bladder channel, tonneau is urinated, drying expels the heat-evil.Radix Aconiti Lateralis Preparata: suffering, big heat, poisonous, current 12 warps, recuperating depleted YANG and rescuing the patient from collapse, supporing yang capable water, cold relieving pain relieving.Radix Sophorae Flavescentis: hardship, cold, GUIXIN, spleen, large intestine, kidney channel, heat clearing and damp drying, killing parasites for relieving itching, tonneau urine.Herba Patriniae: suffering, hardship is slightly cold, and returns stomach, large intestine, Liver Channel, heat-clearing and toxic substances removing, clots absorbing evacuation of pus.Herba Taraxaci: hardship, sweet, cold, return liver, stomach warp, heat-clearing and toxic substances removing, mass dissipating and swelling eliminating still have diuresis.Herba Cirsii: sweet, cold, GUIXIN, small intestinal, urinary bladder channel, cooling blood for hemostasis, removing blood stasis.Herba Houttuyniae: suffering, be slightly cold, return lung, kidney, urinary bladder channel, separate pyretic toxicity, subduing inflammation, inducing diuresis for treating stranguria syndrome.Radix Glycyrrhizae: sweet, flat, return spleen, stomach, the heart, lung meridian, invigorating the spleen and replenishing QI, relieving spasm to stop pain, heat-clearing and toxic substances removing, the mediation property of medicine.More than all medicines share, can the efficacious therapy chronic pyelonephritis, cure rate is high, does not recur after more.Excess is not found side effect with Herba Patriniae and Herba Taraxaci.
Method of administration and consumption: side's survival dose of the present invention is adult's amount, and child, old man are cut down according to the circumstance.This decoction decocts twice altogether, and first pass is fried boiling with high heat, changes slow fire again and is fried boiling 30 minutes, leaches the 150ml medicinal liquid, is fried boiling with high heat for second time, changes slow fire again and is fried boiling 40 minutes, leaches the 150ml medicinal liquid, twice mixing, divide 2 times sooner or later 30 minutes ante cibum decoction being taken warmly.
The specific embodiment:
Below in conjunction with embodiment the present invention is described further.
Embodiment 1: a kind of Chinese medicine of treating chronic pyelonephritis, form by the component of following raw materials in weight drug ratio: Radix Astragali 40-45g, Radix Angelicae Sinensis 20-25g, Radix Rehmanniae 30-35g, Fructus Corni 20-23g, Rhizoma Dioscoreae 20-23g, Cortex Moutan 10-12g, Poria 10-12g, Rhizoma Alismatis 10-12g, Radix Aconiti Lateralis Preparata 10-12g, Radix Sophorae Flavescentis 20-25g, Herba Patriniae 60-65g, Herba Taraxaci 60-65g, Herba Cirsii 30-35g, Herba Houttuyniae 30-35g, Radix Glycyrrhizae 10-12g.
Embodiment 2: a kind of Chinese medicine of treating chronic pyelonephritis, its preferably: Radix Astragali 40g, Radix Angelicae Sinensis 20g, Radix Rehmanniae 30g, Fructus Corni 20g, Rhizoma Dioscoreae 20g, Cortex Moutan 10g, Poria 10g, Rhizoma Alismatis 10g, Radix Aconiti Lateralis Preparata 10g, Radix Sophorae Flavescentis 20g, Herba Patriniae 60g, Herba Taraxaci 60g, Herba Cirsii 30g, Herba Houttuyniae 30g, Radix Glycyrrhizae 10g.
A kind of Chinese medicine clinical efficacy of treating chronic pyelonephritis is summed up
Physical data: side's medicine of the present invention is applied to clinical for many years, treats tens of routine patients, good effect.Criterion of therapeutical effect: cure: the clinical symptoms complete obiteration.Twice inspection, January, once routine urinalysis was normal, and urine thin bacterium quantitative culture is negative.Take a turn for the better: clinical symptoms complete obiteration, routine urinalysis are seen has white cell cast, urine thin bacterium quantitative culture (+-).Invalid: clinical symptoms remains unchanged or increases the weight of, and routine urinalysis is undesired, and urine thin bacterium quantitative culture is positive.
Side's medicine of the present invention, generally taking 10 days is a course of treatment, and the patient who takes medicine at most takes medicine 4 courses of treatment, and the minimum patient who takes medicine takes medicine 2 courses of treatment.Add up 3 courses of treatment to take medicine: cure rate 80%, improvement rate 15%, invalid case 5%.
Diagnostic criteria: 1, the course of disease of pyelonephritis surpasses half a year, simultaneously with one of scenario person diagnosable be chronic pyelonephritis: A, repeatedly urine thin bacterium quantitative culture is positive.B, kidney profile are uneven, and the kidney unsymmetry is dwindled, renal pelvis, renal calices distortion and constriction.C, renal tubular function have the persistence infringement.2, atypia person can show as ABU, secondary hypertensive episode hematuria or prolonged low grade fever etc.3, get rid of the kidney tuberculosis of bladder.
Model case:
Case 1, slowly * *, the woman, 28 years old, married, the workman.Go to a doctor in May, 1998.Make a definite diagnosis through central hospital and to suffer from chronic pyelonephritis 8 months, oral antibiotic sheet time and again, vein is given antibiotics when serious, but heavy when light during the state of an illness.Introduce here treatment through the ward mate specifically, take side's medicine of the present invention after course of treatment, conscious recovering for anti-recurrence, obeyed a course of treatment again, after repeatedly routine urianlysis is normal, urine thin bacterium quantitative culture is negative.Followed up a case by regular visits to 5 years, not recurrence.
Case 2, king * *, the woman, 37 years old, married, the peasant.Go to a doctor in July, 2002.Made a definite diagnosis chronic pyelonephritis 9 months through municipal hospital.Antibiotics sheet and Chinese herbal medicine have also been taken many, but the time outbreak arranged.Introduce here treatment through the ward mate specifically, it is good to take a side's medicine aftersensation course of treatment of the present invention, for effecting a radical cure this disease, obeys drug withdrawal after 2 courses of treatment again, after repeatedly routine urianlysis is normal, urine thin bacterium quantitative culture is negative, follows up a case by regular visits to not recurrence in 3 years.

Claims (1)

1. Chinese medicine of treating chronic pyelonephritis is characterized in that it is made up of the component of following raw materials in weight drug ratio: Radix Astragali 40-45g, Radix Angelicae Sinensis 20-25g, Radix Rehmanniae 30-35g, Fructus Corni 20-23g, Rhizoma Dioscoreae 20-23g, Cortex Moutan 10-12g, Poria 10-12g, Rhizoma Alismatis 10-12g, Radix Aconiti Lateralis Preparata 10-12g, Radix Sophorae Flavescentis 20-25g, Herba Patriniae 60-65g, Herba Taraxaci 60-65g, Herba Cirsii 30-35g, Herba Houttuyniae 30-35g, Radix Glycyrrhizae 10-12g.
CN2012101531352A 2012-05-17 2012-05-17 Chinese medicament for treating chronic pyelonephritis Pending CN102670919A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101531352A CN102670919A (en) 2012-05-17 2012-05-17 Chinese medicament for treating chronic pyelonephritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101531352A CN102670919A (en) 2012-05-17 2012-05-17 Chinese medicament for treating chronic pyelonephritis

Publications (1)

Publication Number Publication Date
CN102670919A true CN102670919A (en) 2012-09-19

Family

ID=46803904

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101531352A Pending CN102670919A (en) 2012-05-17 2012-05-17 Chinese medicament for treating chronic pyelonephritis

Country Status (1)

Country Link
CN (1) CN102670919A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103721132A (en) * 2014-01-24 2014-04-16 管心平 Chinese medicinal preparation for treating nephritis
CN105079487A (en) * 2015-09-26 2015-11-25 冷国玉 Traditional Chinese medicine composition for treating heat stranguria
CN106166249A (en) * 2016-09-23 2016-11-30 四川金堂海纳生物医药技术研究所 A kind of decoction medicine treating chronic pyelonephritis and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102370853A (en) * 2011-10-18 2012-03-14 文登市大水泊镇乐园村卫生室 Traditional Chinese medicine for treating chronic pyelonephritis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102370853A (en) * 2011-10-18 2012-03-14 文登市大水泊镇乐园村卫生室 Traditional Chinese medicine for treating chronic pyelonephritis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103721132A (en) * 2014-01-24 2014-04-16 管心平 Chinese medicinal preparation for treating nephritis
CN105079487A (en) * 2015-09-26 2015-11-25 冷国玉 Traditional Chinese medicine composition for treating heat stranguria
CN106166249A (en) * 2016-09-23 2016-11-30 四川金堂海纳生物医药技术研究所 A kind of decoction medicine treating chronic pyelonephritis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101934025B (en) Traditional Chinese medicine for clearing away heat and toxic material
CN102973862B (en) Chinese medicine preparation for treating skin itch
CN102940865B (en) Externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof
CN102512617B (en) Chinese herbal preparation for treating psoriasis
CN101024026A (en) Medicine for treating parotitis
CN101966295A (en) Medicament for treating chronic amygdalitis
CN102670919A (en) Chinese medicament for treating chronic pyelonephritis
CN102370853A (en) Traditional Chinese medicine for treating chronic pyelonephritis
CN101618172B (en) Traditional Chinese medicine for treating hepatitis B, cirrhosis, liver cancer and liver ascites
CN101856455B (en) Chinese medicament for treating psoriasis vulgaris
CN101385821B (en) Asthma control coating agent and preparation technique thereof
CN103845580A (en) Traditional Chinese medicine composition for treating allergic rhinitis
CN103099879B (en) Traditional Chinese medicine (TCM) preparation for treating fifth-watch diarrhea
CN105194165B (en) Traditional Chinese medicine used for treating infection of urinary system and preparation method thereof
CN103127320A (en) Itching relieving and anti-allergic Chinese medicinal compound umbilical patch
CN115804805B (en) Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag
CN102614479A (en) Traditional Chinese medicine lotion preparation method for curing kidney-yang deficiency ecthyma
CN101954018A (en) Oral medicament for treating chronic nephritis
CN101912566B (en) Traditional Chinese medicine for treating palpitation
CN104721572B (en) A kind of Chinese medicine for treating chronic colitis
CN103989885A (en) Traditional Chinese medicine for treating chronic pelvic inflammation
CN105267386A (en) Fever cooling patch
CN104706902A (en) Traditional Chinese medicine composition for treating allergic rhinitis
CN103877295A (en) Traditional-Chinese-medicine composition for treating psoriasis by oral administration and external applying
CN103393948B (en) Traditional Chinese medicine preparation for treating nongonococcal urethritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120919